Business
from24/7 Wall St.
3 weeks agoWhy Eli Lilly's $1 Billion AI Bet Could Reshape Drug Discovery
Eli Lilly's GLP-1 drug surge, AI-enabled R&D, and strong Q4 2025 results propelled the stock near all-time highs and drove bullish retail sentiment.